Asset

DELAFLOXACIN MEGLUMINE

CorMedix Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (2)

ApplicationApprovedTypeApplicant
NDA 2086102017-06-19NDAMELINTA SUBSIDIARY CORP
NDA 2086112017-06-19NDAMELINTA SUBSIDIARY CORP

Marketed products (2)

  • BAXDELA
  • BAXDELA